Author Question: When neither the person taking the drug nor the person evaluating the effects of the drug knows ... (Read 61 times)

jc611

  • Hero Member
  • *****
  • Posts: 552
When neither the person taking the drug nor the person evaluating the effects of the drug knows which people are getting the experimental drug and which people are getting the placebo, this procedure is referred to as a(n)
 
  A. design flaw.
  B. effect size.
  C. preclinical study.
  D. double-blind procedure.

Question 2

Why was the 18th Amendment prohibiting alcohol such an important influence on the federal approach to regulating opioids and cocaine?
 
  What will be an ideal response?



anyusername12131

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

D

Answer to Question 2

The Narcotics Division in the Treasury department had been small and focused mainly on opium smuggling. Prohibition created a larger enforcement arm within Treasury, and Narcotics was placed under that. This agency now took a prohibition approach to narcotics, trying to prevent users from getting them. They closed down treatment clinics and arrested many physicians and pharmacists who supplied drugs to dependent users. Bonus: This was not due to a change in drug laws, but to a restructuring of the bureaucracy.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

The senior population grows every year. Seniors older than 65 years of age now comprise more than 13% of the total population. However, women outlive men. In the 85-and-over age group, there are only 45 men to every 100 women.

Did you know?

Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library